法巴健康護理創新股票基金 C (美元)
319.36美元0.71(0.22%)
2023/09/22更新
此子基金主要投資於全球健康護理行業內的公司股票。這些公司可包括製藥公司、保健產品和醫療服務產品公司、生物科技公司,以及醫療材料和設備的製造商及 醫用電腦公司。此基金的管理遵循自下而上的投資方法,即在選擇股票時,強調首先分析每種股票的具體特點。基金經理基於國際健康護理行業的股票分類進行股 票選擇。基金經理的職責為構建呈現出良好的風險/收益比率的分散化股票投資組合。若有利的投資機會出現,此基金亦可投資於其他金融工具。
大型 | |||
---|---|---|---|
中型 | |||
小型 | |||
價值型 | 均衡型 | 增長型 |
Chris Fay joined BNP Paribas Asset Management in 2013 from Pioneer Investment Management in Boston where he was a portfolio manager and analyst covering the global health care sector. Prior to that, he was an institutional healthcare consultant with Leerink Swann & Co. and Kendall Strategies Inc. Earlier in his career he was employed by The Massachusetts Department of Public Health as the Chief of Administration and Finance. Chris earned his B.A. from the George Washington University. He received a M.S. in Biology from Loyola University of Chicago, a Masters in Public Health from Boston University and an M.B.A. from the Carroll School of Management, Boston College.
Jon manages the team’s investments in the health care sector and is the lead portfolio manager on its Health Care Innovators strategy . Earlier in his career, Jon spent five years with Pioneer Investments as a portfolio manager, working on a range of growth strategies. Previous to that, Jon was Director of Research with Summer Street Research Partners. Early in his career, he worked with State Street Research & Management as a research analyst covering the health care sector. He earned his BA from the Bucknell University. A member of the CFA Institute, Jon is a CFA charterholder